Tisztelettel meghívjuk Önöket a 15. alkalommal, online formában megszervezésre kerülő Korányi Sándor Hipertónia Nefrológia Napra a Semmelweis Egyetem Belgyógyászati és Onkológiai Klinika rendezésében, 2025. április 12-én, szombaton.

Korányi Sándor Professzor, a magyarországi nefrológia megalapítójának és a keringési rendszer kutatójának neve összeforrt a Belklinika történetével - rendezvényünkkel előtte is tisztelgünk. Az időpontnak keretet ad a Vese Világnapja március 14.-én és a Hipertónia Világnapja május 17.-én, aktualitása ugyanakkor Korányi Sándor professzor halálának 81. évfordulója 2025. április 12-én.

Bár a belklinikai előadóterem múlt század eleji varázsának és a személyes találkozások baráti körének élvezetére nem ad lehetőséget (amit szomorúan veszünk tudomásul), ugyanakkor a minél szélesebb körű - akár a határon túlnyúló - részvétel és a tanfolyam díjmentességének biztosítása iránti igény miatt a tanfolyam online folytatása mellett döntöttünk.

A szabadon választható továbbképzést ajánljuk családorvos, belgyógyász, diabetológus, kardiológus és nefrológus kollégák számára.

A továbbképzés a Semmelweis Egyetem Továbbképzési Központban került akkreditálásra.

Időpont: 2025.04.12. szombat, 08:50-15.30

Helyszín: ONLINE (Zoom linket a rendezvény előtt küldjük)

Részvételi díj: nincs, de jelentkezés szükséges a www.oftex.hu oldalon

További információ: Kiss-Láng Zsuzsanna titkárnőnél (lang.zsuzsanna@med.semmelweis-univ.hu)

A meghívó és a program megtekinthető ide kattintva
 

• Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
• Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
• Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

•  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
•  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
• Abstracts should adhere to the specified format and guidelines provided on the conference website.

• Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
• Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
• Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

•  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
•  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
• Abstracts should adhere to the specified format and guidelines provided on the conference website.

• Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
• Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
• Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

•  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
•  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
• Abstracts should adhere to the specified format and guidelines provided on the conference website.

• Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
• Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
• Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

•  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
•  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
• Abstracts should adhere to the specified format and guidelines provided on the conference website.

• Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
• Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
• Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

•  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
•  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
• Abstracts should adhere to the specified format and guidelines provided on the conference website.